Record overview
Status and phase
Status:
Phase: PHASE2
Sponsor: Mirati Therapeutics
Condition: NSCLC
NCTCPRR001
Lumicras in KRAS G12C NSCLC
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal | long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.